시장보고서
상품코드
1429905

세계의 약물감시 시장 보고서(2024년)

Pharmacovigilance Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 200 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

약물감시 시장 규모는 향후 수년간 급속히 성장할 것으로 예상되고 있습니다. 2028년에는 12.9%의 연간 복합 성장률(CAGR)로 141억 1,000만 달러로 성장할 것으로 예상됩니다. 예측 기간 중 예상되는 성장은 의료비 증가, 정부 지원 증가, 인구 고령화 등의 요인에 기인할 것으로 보입니다. 예측 기간 중 예상되는 주요 동향으로는 투자 증가, 인공지능 사용, 혁신적인 플랫폼 채택, 혁신적인 클라우드 기반 시스템 활용, 전략적 인수합병 등이 있습니다.

제약 분야의 연구개발(R&D) 활동이 증가함에 따라 약물감시 시장은 성장할 것으로 예상됩니다. R&D에 대한 투자를 통해 제약회사는 안전성 프로파일이 개선된 신약을 개발할 수 있습니다. 의약품 개발 중 엄격한 전임상 및 임상시험은 잠재적인 안전성 문제를 조기에 파악하여 위험 감소 전략을 적시에 실행할 수 있도록 돕습니다. 또한 연구개발 노력은 부작용 모니터링, 데이터 분석 및 신호 감지 기술의 발전에 기여하여 시판 후 부작용을 조기에 발견할 수 있도록 돕습니다. 2022년 2월 IQVIA의 조사에 따르면 미국내 벤처캐피털의 거래 활동과 투자가 크게 증가했으며, 제약회사들은 2021년에 R&D에 1,330억 달러를 투자해 전년 대비 44% 증가한 사상 최고치를 기록한 것이 밝혀졌습니다. 이러한 R&D 활동의 급증은 약물감시 시장의 성장을 지원하고 있습니다.

약물감시 시장은 의료비 증가로 인해 성장할 것으로 예상됩니다. 의료 시스템은 자금 증가로 인해 약물 부작용을 효율적으로 식별하고 평가할 수 있는 첨단 기술, 데이터 분석 및 전문가 팀에 투자할 수 있게 됩니다. 또한 의료 지출 증가는 약물감시 관행에 대한 의료 전문가 교육 및 교육을 강화하여 잠재적인 약물 관련 문제를 적시에보고하고 분석 할 수 있도록 보장할 것입니다. 2031년까지 GDP의 19.6%를 나타낼 것으로 예측했습니다. 또한 미국 만성질환 책임자 협회는 성인 미국인의 거의 60%가 적어도 한 가지 이상의 만성질환을 앓고 있다고 보고하여 그 필요성을 강조합니다. 의료비 증가를 향해 이러한 의료비 지출 증가 추세는 약물감시 시장을 촉진할 것으로 예상됩니다.

목차

제1장 주요 요약

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • 시장에 대한 COVID-19의 영향

제5장 세계 시장 규모와 성장

  • 세계의 약물감시 시장 촉진요인과 억제요인
    • 시장 촉진요인
    • 시장 억제요인
  • 세계의 약물감시 시장 규모 실적과 성장, 2018-2023년
  • 세계의 약물감시 시장 규모와 성장 예측, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 약물감시 시장, 유형별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 자발적 보고
  • ADR 보고의 강화
  • 표적화된 자발적 보고
  • 코호트 이벤트 모니터링
  • EHR 마이닝
  • 세계의 약물감시 시장, 서비스 프로바이더별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 사내
  • 계약 업무 위탁
  • 세계의 약물감시 시장, 프로세스 플로우별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 증례 데이터 관리
  • 신호 탐지
  • 리스크 관리 체제
  • 세계의 약물감시 시장, 임상시험 단계별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 전임상
  • 단계 I
  • 단계 II
  • 단계 III
  • 단계 IV
  • 세계의 약물감시 시장, 최종사용자별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 병원
  • 제약회사
  • 기타

제7장 지역과 국가 분석

  • 세계의 약물감시 시장, 지역별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 약물감시 시장, 국가별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • 약물감시 시장의 경쟁 구도
  • 약물감시 시장의 기업 개요
    • IQVIA
    • Cognizant
    • ICON Plc
    • Accenture plc
    • PAREXEL International Corporation.

제31장 기타 대기업과 혁신적 기업

  • United BioSource LLC
  • ArisGlobal
  • Quanticate
  • Wipro Limited
  • Linical Americas
  • Novotech CRO
  • Wuxi Apptec
  • Simcere Pharmaceutical Group
  • Lee's Pharmaceutical Holdings
  • Luye Pharma Group
  • EXTEDO
  • Arriello
  • PrimeVigilance
  • Axios International
  • C3i Solutions

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 합병과 인수

제35장 향후 전망과 잠재성 분석

제36장 부록

KSA 24.03.15

Pharmacovigilance encompasses the science and practices dedicated to identifying, evaluating, understanding, and mitigating side effects and other medical/vaccination-related issues. Its purpose is to assess whether the benefits of a drug outweigh its risks, and this scrutiny persists even after drug approval.

The primary types of pharmacovigilance include spontaneous reporting, intensified adverse drug reaction (ADR) reporting, targeted spontaneous reporting, cohort event monitoring, and electronic health record (EHR) mining. Spontaneous reporting relies on individuals' voluntary reporting of suspected adverse drug reactions to local or national pharmacovigilance centers, representing a passive approach. Process flows involve case data management, signal detection, and risk management systems. Service providers can be in-house or contracted for outsourcing, covering various clinical trial phases such as preclinical, phase I, phase II, phase III, and phase IV. These services cater to different end-users, including hospitals, pharmaceutical companies, and others.

The pharmacovigilance market research report is one of a series of new reports from The Business Research Company that provides pharmacovigilance market statistics, including pharmacovigilance industry global market size, regional shares, competitors with a pharmacovigilance market share, detailed pharmacovigilance market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmacovigilance industry. This pharmacovigilance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmacovigilance market size has grown rapidly in recent years. It will grow from $7.63 billion in 2023 to $8.67 billion in 2024 at a compound annual growth rate (CAGR) of 13.6%. The expansion observed in the historical period can be attributed to the increasing incidence of adverse drug reactions (ADRs), rising research and development (R&D) activities, growing rates of drug development, an increased focus on personalized medicine, and the rising prevalence of chronic diseases.

The pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $14.11 billion in 2028 at a compound annual growth rate (CAGR) of 12.9%. The anticipated growth in the forecast period can be attributed to factors such as the rising healthcare expenditure, increasing government support, and the aging population. Key trends expected in the forecast period include increasing investments, the use of artificial intelligence, adoption of innovative platforms, utilization of innovative cloud-based systems, and strategic mergers and acquisitions.

The pharmacovigilance market is set to experience growth due to increasing research and development (R&D) activities in the pharmaceutical sector. Investments in R&D enable pharmaceutical companies to develop new drugs with improved safety profiles. Rigorous preclinical and clinical testing during drug development aids in early identification of potential safety concerns, allowing for timely implementation of risk mitigation strategies. Additionally, R&D efforts contribute to the advancement of technologies for adverse event monitoring, data analysis, and signal detection, facilitating early detection of adverse drug reactions post-marketing. A study by IQVIA in February 2022 revealed a significant increase in venture capital deal activity and investments in the U.S., with pharmaceutical giants investing a record $133 billion in R&D in 2021, marking a 44% increase over previous years. This surge in R&D activities supports the growth of the pharmacovigilance market.

The pharmacovigilance market is expected to witness growth propelled by rising healthcare expenditure. Increased funding enables healthcare systems to invest in advanced technologies, data analytics, and expert teams for efficient identification and assessment of adverse drug reactions. Higher healthcare spending also facilitates better training and education of healthcare professionals on pharmacovigilance practices, ensuring timely reporting and analysis of potential drug-related issues. The Centers for Medicare & Medicaid Services projects an increase in National Health Expenditures, reaching 19.6% of GDP by 2031. Additionally, the National Association of Chronic Disease Directors reported that almost 60% of adult Americans have at least one chronic disease, emphasizing the need for increased healthcare expenditure. This upward trajectory in healthcare spending is expected to drive the pharmacovigilance market.

Pharmacovigilance market players are strategically adopting artificial intelligence (AI) to enhance efficiency. AI contributes to improved accuracy and efficiency in pharmacovigilance activities, leading to better patient outcomes. Pharma companies utilizing AI can streamline processes, enhance data management, and expedite drug discovery while reducing costs and enhancing safety. For instance, Deloitte and Sanofi collaborated on an AI software-as-a-service adverse events case intake platform called ConvergeHEALTH Safety to modernize pharmacovigilance. Sanofi reported increased case quality and processing efficiency within pharmacovigilance through the automation of case intake. The integration of AI is a significant focus in the pharmacovigilance market.

Pharmacovigilance providers are making substantial investments to expand their product portfolios and geographic presence. In September 2022, the PharmaLex Group opened a new branch in Beijing, China, offering comprehensive pharmacovigilance, regulatory affairs, development advice, and quality management services to global companies entering the Chinese market. The PharmaLex Group's expansion aims to provide enhanced support and value across the product lifecycle.

In January 2023, AmerisourceBergen acquired Pharma Lex to augment its existing service offering and provide pharmaceutical and biotech companies with comprehensive support for pharmacovigilance systems and operations, including benefit-risk management services. These strategic investments contribute to the growth and expansion of the pharmacovigilance market.

Major companies operating in the pharmacovigilance market report are IQVIA, Cognizant, ICON PLC, Accenture PLC, PAREXEL International Corporation., United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, Wuxi Apptec, Simcere Pharmaceutical Group, Lee's Pharmaceutical Holdings, Luye Pharma Group, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Alcon, Secure AI Labs, OmniSol dot Tech, Canna Call Company, Veripad, Prevnos Inc., Lifescient, Inc., BeiGene, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., MSD, Novasyte, Fortrea Holdings Inc., Syneos Health Clinical, Zoetis Inc., Telerx Marketing Inc., Gilead Sciences, Inc., Elanco, Abbott Laboratories, Spimaco, Teva Pharmaceutical Industries Ltd., DSV Healthcare

North America was the largest region in the pharmacovigilance market in 2023. Asia-Pacific is expected to be the fastest growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacovigilance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The pharmacovigilance market includes revenues earned by collecting, analyzing, monitoring, and preventing adverse effects in drugs and therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmacovigilance Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmacovigilance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmacovigilance? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmacovigilance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Spontaneous Reporting; Intensified ADR Reporting; Targeted Spontaneous Reporting; Cohort Event Monitoring; EHR Mining
  • 2) By Service Provider: In-House; Contract Outsourcing
  • 3) By Process Flow: Case Data Management; Signal Detection; Risk Management System
  • 4) By Clinical Trial Phases: Preclinical; Phase I; Phase II; Phase III; Phase IV
  • 5) By End User: Hospitals; Pharmaceutical Companies; Other End Users
  • Companies Mentioned: IQVIA; Cognizant; ICON Plc; Accenture plc; PAREXEL International Corporation.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmacovigilance Market Characteristics

3. Pharmacovigilance Market Trends And Strategies

4. Pharmacovigilance Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pharmacovigilance Market Size and Growth

  • 5.1. Global Pharmacovigilance Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pharmacovigilance Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pharmacovigilance Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmacovigilance Market Segmentation

  • 6.1. Global Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining
  • 6.2. Global Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • In-House
  • Contract Outsourcing
  • 6.3. Global Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Case Data Management
  • Signal Detection
  • Risk Management System
  • 6.4. Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Preclinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • 6.5. Global Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Pharmaceutical Companies
  • Other End Users

7. Pharmacovigilance Market Regional And Country Analysis

  • 7.1. Global Pharmacovigilance Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pharmacovigilance Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmacovigilance Market

  • 8.1. Asia-Pacific Pharmacovigilance Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmacovigilance Market

  • 9.1. China Pharmacovigilance Market Overview
  • 9.2. China Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmacovigilance Market

  • 10.1. India Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmacovigilance Market

  • 11.1. Japan Pharmacovigilance Market Overview
  • 11.2. Japan Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmacovigilance Market

  • 12.1. Australia Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmacovigilance Market

  • 13.1. Indonesia Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmacovigilance Market

  • 14.1. South Korea Pharmacovigilance Market Overview
  • 14.2. South Korea Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmacovigilance Market

  • 15.1. Western Europe Pharmacovigilance Market Overview
  • 15.2. Western Europe Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmacovigilance Market

  • 16.1. UK Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmacovigilance Market

  • 17.1. Germany Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmacovigilance Market

  • 18.1. France Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmacovigilance Market

  • 19.1. Italy Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmacovigilance Market

  • 20.1. Spain Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmacovigilance Market

  • 21.1. Eastern Europe Pharmacovigilance Market Overview
  • 21.2. Eastern Europe Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmacovigilance Market

  • 22.1. Russia Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmacovigilance Market

  • 23.1. North America Pharmacovigilance Market Overview
  • 23.2. North America Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmacovigilance Market

  • 24.1. USA Pharmacovigilance Market Overview
  • 24.2. USA Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmacovigilance Market

  • 25.1. Canada Pharmacovigilance Market Overview
  • 25.2. Canada Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmacovigilance Market

  • 26.1. South America Pharmacovigilance Market Overview
  • 26.2. South America Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmacovigilance Market

  • 27.1. Brazil Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmacovigilance Market

  • 28.1. Middle East Pharmacovigilance Market Overview
  • 28.2. Middle East Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmacovigilance Market

  • 29.1. Africa Pharmacovigilance Market Overview
  • 29.2. Africa Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmacovigilance Market Competitive Landscape And Company Profiles

  • 30.1. Pharmacovigilance Market Competitive Landscape
  • 30.2. Pharmacovigilance Market Company Profiles
    • 30.2.1. IQVIA
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Cognizant
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. ICON Plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Accenture plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. PAREXEL International Corporation.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pharmacovigilance Market Other Major And Innovative Companies

  • 31.1. United BioSource LLC
  • 31.2. ArisGlobal
  • 31.3. Quanticate
  • 31.4. Wipro Limited
  • 31.5. Linical Americas
  • 31.6. Novotech CRO
  • 31.7. Wuxi Apptec
  • 31.8. Simcere Pharmaceutical Group
  • 31.9. Lee's Pharmaceutical Holdings
  • 31.10. Luye Pharma Group
  • 31.11. EXTEDO
  • 31.12. Arriello
  • 31.13. PrimeVigilance
  • 31.14. Axios International
  • 31.15. C3i Solutions

32. Global Pharmacovigilance Market Competitive Benchmarking

33. Global Pharmacovigilance Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmacovigilance Market

35. Pharmacovigilance Market Future Outlook and Potential Analysis

  • 35.1 Pharmacovigilance Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pharmacovigilance Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pharmacovigilance Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제